AMBB.Y Stock Overview
A medical technology company, develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Ambu A/S Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | DKK 16.88 |
| 52 Week High | DKK 22.65 |
| 52 Week Low | DKK 13.14 |
| Beta | 0.79 |
| 11 Month Change | -8.51% |
| 3 Month Change | -22.57% |
| 1 Year Change | 31.06% |
| 33 Year Change | -41.79% |
| 5 Year Change | -1.75% |
| Change since IPO | 27.88% |
Recent News & Updates
Recent updates
Shareholder Returns
| AMBB.Y | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -3.1% | -1.2% | -2.1% |
| 1Y | 31.1% | 22.4% | 29.6% |
Return vs Industry: AMBB.Y exceeded the US Medical Equipment industry which returned 22.4% over the past year.
Return vs Market: AMBB.Y exceeded the US Market which returned 29.6% over the past year.
Price Volatility
| AMBB.Y volatility | |
|---|---|
| AMBB.Y Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 8.0% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.5% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: AMBB.Y's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine AMBB.Y's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1937 | 5,196 | Britt Jensen | www.ambu.com |
Ambu A/S, a medical technology company, develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, and displaying units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.
Ambu A/S Fundamentals Summary
| AMBB.Y fundamental statistics | |
|---|---|
| Market cap | US$4.47b |
| Earnings (TTM) | US$33.17m |
| Revenue (TTM) | US$760.83m |
134.8x
P/E Ratio5.9x
P/S RatioIs AMBB.Y overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AMBB.Y income statement (TTM) | |
|---|---|
| Revenue | DKK 5.39b |
| Cost of Revenue | DKK 2.19b |
| Gross Profit | DKK 3.20b |
| Other Expenses | DKK 2.97b |
| Earnings | DKK 235.00m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Jan 30, 2025
| Earnings per share (EPS) | 0.88 |
| Gross Margin | 59.38% |
| Net Profit Margin | 4.36% |
| Debt/Equity Ratio | 0% |
How did AMBB.Y perform over the long term?
See historical performance and comparisonDividends
0.3%
Current Dividend Yield43%
Payout RatioDoes AMBB.Y pay a reliable dividends?
See AMBB.Y dividend history and benchmarks| Ambu dividend dates | |
|---|---|
| Ex Dividend Date | Dec 06 2024 |
| Dividend Pay Date | Dec 23 2024 |
| Days until Ex dividend | 17 days |
| Days until Dividend pay date | 34 days |
Does AMBB.Y pay a reliable dividends?
See AMBB.Y dividend history and benchmarks